MRSEI - Montage de Réseaux Scientifiques Européens ou Internationaux

International network to secure anticancer drug treatments through personalized approaches: Application to fluoropyrimidines. – ONCOSAFE

Project coordination

Marie-Christine Etienne-Grimaldi (Centre Antoine Lacassagne, Nice, France)

The author of this summary is the project coordinator, who is responsible for the content of this summary. The ANR declines any responsibility as for its contents.

Partner

CAL Centre Antoine Lacassagne, Nice, France
Centre Hospitalier Universitaire, Unité de Toxicologie, Laboratoire de Biochimie, Nîmes, France
University of Pisa, Department of Clinical and Experimental Medecine, Division of Pharmacology, Pisa, Italy
Academic Medical Center, Lab. Genetic Metabolic Diseases, Amsterdam, the Netherlands
Faculté de Médecine, Unité de Pharmacogénétique, Lab. de Biochimie et Biologie Moléculaire, Tours, France
INSERM-UMRS910, Faculté de Médecine La Timone, Marseille, France
IURC Institut Universitaire de Recherche Clinique, Faculté de Médecine, Montpellier, France
Moffitt Cancer Center, Personalized Medicine Institute, Division of Population Sciences, Tampa, FL, USA
IUCT Institut Universitaire du Cancer, Lab. de Biologie Médicale Oncologique , Toulouse, France

Help of the ANR 30,000 euros
Beginning and duration of the scientific project: October 2015 - 18 Months

Useful links

Explorez notre base de projets financés

 

 

ANR makes available its datasets on funded projects, click here to find more.

Sign up for the latest news:
Subscribe to our newsletter